Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: July's freshest AI-picked stocks >>>
Unlock Stocks
Close

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF (1621)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
25,470.0 -250.0    -0.97%
07:30:29 - Closed. Currency in JPY
Type:  ETF
Market:  Japan
ISIN:  JP3046600007 
Asset Class:  Equity
  • Volume: 259
  • Bid/Ask: 25,415.0 / 25,470.0
  • Day's Range: 25,345.0 - 25,675.0
NEXT FUNDS TOPIX-17 Pharmaceutical 25,470.0 -250.0 -0.97%

1621 Candlestick Patterns

 
Dozens of bullish and bearish live candlestick chart patterns for the NEXT FUNDS TOPIX-17 Pharmaceutical ETF and use them to help predict future market behaviour. The NEXT FUNDS TOPIX-17 Pharmaceutical ETF patterns are available in a variety of time frames for both long and short term investments. Gain a trading edge with our auto pattern recognition feature and enjoy insights into what the patterns mean.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customise

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Falling Three Methods 1M Current
Homing Pigeon 5H Current
Inverted Hammer 30 Current
Completed Patterns
Harami Bullish 1D 1 Jul 02, 2025
Engulfing Bearish 1W 2 Jun 15, 2025
Bullish Hammer 1M 3 Apr 25
Harami Cross 1W 3 Jun 08, 2025
Harami Bullish 1M 4 Mar 25
Harami Cross 1M 4 Mar 25
Falling Three Methods 1W 4 Jun 01, 2025
Three Inside Up 1W 5 May 25, 2025
Harami Bearish 1D 5 Jun 26, 2025
Three Inside Down 5H 6 Jul 01, 2025 02:00
Three Outside Up 1D 7 Jun 24, 2025
Harami Bearish 5H 7 Jun 30, 2025 06:00
Bullish Engulfing 1D 8 Jun 23, 2025
Three Inside Down 15 9 Jul 03, 2025 06:00
Engulfing Bearish 1M 10 Sep 24
Harami Bearish 15 10 Jul 03, 2025 05:45
Hanging Man 5H 11 Jun 26, 2025 22:00
Hanging Man 1M 13 Jun 24
Evening Doji Star 1W 13 Mar 30, 2025
Doji Star Bearish 1W 14 Mar 23, 2025
Three Black Crows 1D 14 Jun 13, 2025
Two Crows 1D 15 Jun 12, 2025
Doji Star Bearish 5H 17 Jun 24, 2025 00:00
Belt Hold Bullish 1H 17 Jul 01, 2025 04:00
Morning Star 1W 18 Feb 23, 2025
Morning Doji Star 1W 18 Feb 23, 2025
Bullish doji Star 1W 19 Feb 16, 2025
Dragonfly Doji 5H 19 Jun 22, 2025 23:00
Harami Bullish 1M 20 Nov 23
Three Black Crows 1D 20 Jun 05, 2025
Three Outside Down 1D 21 Jun 04, 2025
Belt Hold Bearish 1D 22 Jun 03, 2025
Engulfing Bearish 1D 22 Jun 03, 2025
Belt Hold Bullish 5H 22 Jun 19, 2025 05:00
Inverted Hammer 1W 23 Jan 19, 2025
Engulfing Bearish 1M 24 Jul 23
Inverted Hammer 5H 24 Jun 18, 2025 04:00
Shooting Star 1M 25 Jun 23
Falling Three Methods 1W 25 Jan 05, 2025
Belt Hold Bullish 5H 25 Jun 17, 2025 23:00
Advance Block Bearish 1M 26 May 23
Bullish Engulfing 1W 27 Dec 22, 2024
Morning Star 1W 27 Dec 22, 2024
Three Outside Down 1M 30 Jan 23
Belt Hold Bullish 30 30 Jul 01, 2025 04:00
Engulfing Bearish 1M 31 Dec 22
Evening Doji Star 1M 31 Dec 22
Evening Star 1M 31 Dec 22
Harami Bullish 15 31 Jul 02, 2025 04:00
Harami Cross 15 31 Jul 02, 2025 04:00
Doji Star Bearish 1M 32 Nov 22
Belt Hold Bearish 1D 32 May 20, 2025
Engulfing Bearish 1D 32 May 20, 2025
Belt Hold Bearish 1H 33 Jun 27, 2025 02:00
Bullish Hammer 1H 33 Jun 27, 2025 02:00
Three White Soldiers 15 34 Jul 02, 2025 02:45
Hanging Man 1M 37 Jun 22
Homing Pigeon 1D 37 May 13, 2025
Engulfing Bearish 5H 37 Jun 11, 2025 02:00
Harami Cross Bearish 5H 38 Jun 10, 2025 06:00
Harami Bullish 30 38 Jun 30, 2025 06:30
Harami Cross 30 38 Jun 30, 2025 06:30
Harami Bullish 1H 41 Jun 25, 2025 07:00
Harami Cross 1H 41 Jun 25, 2025 07:00
Tri-Star Bullish 15 41 Jul 01, 2025 07:30
Falling Three Methods 1M 44 Nov 21
Harami Cross 5H 44 Jun 05, 2025 06:00
Belt Hold Bullish 1H 45 Jun 25, 2025 02:00
Inverted Hammer 1H 45 Jun 25, 2025 02:00
Tri-Star Bullish 30 45 Jun 27, 2025 08:30
Belt Hold Bearish 1D 47 Apr 24, 2025
Bullish Hammer 15 47 Jul 01, 2025 05:30
Dragonfly Doji 15 47 Jul 01, 2025 05:30
Engulfing Bearish 1M 48 Jul 21
Belt Hold Bearish 1D 48 Apr 23, 2025
Three Outside Down 5H 48 Jun 03, 2025 04:00
Engulfing Bearish 5H 49 Jun 02, 2025 23:00
Belt Hold Bearish 5H 49 Jun 02, 2025 23:00
Gravestone Doji 1H 52 Jun 24, 2025 02:00
Belt Hold Bullish 15 52 Jul 01, 2025 03:30
Harami Bullish 15 53 Jul 01, 2025 03:15
Belt Hold Bearish 5H 56 May 28, 2025 23:00
Belt Hold Bearish 30 56 Jun 27, 2025 02:00
Bullish Hammer 1H 58 Jun 23, 2025 02:00
Harami Bullish 1M 59 Aug 20
Hanging Man 5H 59 May 27, 2025 22:00
Harami Cross Bearish 1W 60 May 05, 2024
Homing Pigeon 30 62 Jun 26, 2025 05:30
Harami Bullish 15 62 Jun 30, 2025 06:45
Harami Cross 15 62 Jun 30, 2025 06:45
Morning Doji Star 1M 63 Apr 20
Three Inside Up 1M 63 Apr 20
Bullish doji Star 1M 64 Mar 20
Harami Bullish 1M 64 Mar 20
Harami Cross 1M 64 Mar 20
Three Black Crows 1W 64 Apr 07, 2024
Belt Hold Bullish 30 64 Jun 26, 2025 03:00
Belt Hold Bearish 1D 67 Mar 27, 2025
Three Outside Up 1H 68 Jun 19, 2025 06:00
Harami Bullish 30 68 Jun 25, 2025 07:30
Harami Cross 30 68 Jun 25, 2025 07:30
Belt Hold Bullish 1H 69 Jun 19, 2025 05:00
Bullish Engulfing 1H 69 Jun 19, 2025 05:00
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

1621 Comments

Write your thoughts about NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email